Compile Data Set for Download or QSAR

Found 3 hits Enz. Inhib. hit(s) with Target = 'N-formyl peptide receptor 2' and Ligand = 'BDBM454198'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454198 (US10717708, Example 174 | US11186544, Example 174 ...) Show SMILES NC(=O)c1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(F)cc2)C1=O |r| Show InChI InChI=1S/C25H23FN4O3/c26-17-9-11-18(12-10-17)28-25(33)29-22-6-3-15-30(24(22)32)19-13-7-16(8-14-19)20-4-1-2-5-21(20)23(27)31/h1-2,4-5,7-14,22H,3,6,15H2,(H2,27,31)(H2,28,29,33)/t22-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	450	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020) BindingDB Entry DOI: 10.7270/Q2FB560G
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454198 (US10717708, Example 174 | US11186544, Example 174 ...) Show SMILES NC(=O)c1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(F)cc2)C1=O |r| Show InChI InChI=1S/C25H23FN4O3/c26-17-9-11-18(12-10-17)28-25(33)29-22-6-3-15-30(24(22)32)19-13-7-16(8-14-19)20-4-1-2-5-21(20)23(27)31/h1-2,4-5,7-14,22H,3,6,15H2,(H2,27,31)(H2,28,29,33)/t22-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	450	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454198 (US10717708, Example 174 | US11186544, Example 174 ...) Show SMILES NC(=O)c1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(F)cc2)C1=O |r| Show InChI InChI=1S/C25H23FN4O3/c26-17-9-11-18(12-10-17)28-25(33)29-22-6-3-15-30(24(22)32)19-13-7-16(8-14-19)20-4-1-2-5-21(20)23(27)31/h1-2,4-5,7-14,22H,3,6,15H2,(H2,27,31)(H2,28,29,33)/t22-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	450	n/a	n/a	n/a	n/a
TBA					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				Citation and Details BindingDB Entry DOI: 10.7270/Q2B56NXP
					More data for this Ligand-Target Pair